Literature DB >> 3303784

Effect of antithyroid autoantibodies on pancreatic islet-cell function.

N Kitano, T Taminato, M Seno, Y Miyamoto, Y Seino, S Matsukura, H Imura.   

Abstract

Insulin-dependent diabetes mellitus is frequently associated with organ-specific autoimmune diseases and/or high titers of organ-specific autoantibodies. The effects of thyroid autoantibodies on islet-cell function were examined in the present study. Islet cell surface antibody (ICSAb) was detected in sera from 6 of 40 patients with autoimmune thyroid disease (AITD) who were positive for thyroid microsomal autoantibodies (TMA). Furthermore, all of the ICSAb-positive patients had high TMA titers. In vitro study using isolated rat pancreatic islets revealed that TMA positive sera significantly suppressed glucose-induced insulin release. Only one of 19 (5%) AITD patients showed complement-dependent antibody-mediated cytotoxicity and only one of 6 AITD patients (17%) was positive for antibody-dependent cellular cytotoxicity. These results suggest that TMA has an effect on an antigen of the islet cell membrane in which insulin releasing mechanism might be involved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3303784     DOI: 10.1007/BF02732048

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  15 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  Thyroid and gastric autoimmunity in patients with diabetes mellitus.

Authors:  W J Irvine; B F Clarke; L Scarth; D R Cullen; L J Duncan
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

3.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

4.  Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement.

Authors:  T Kanatsuna; A Lernmark; A H Rubenstein; D F Steiner
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

5.  Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.

Authors:  W J Irvine; C J McCallum; R S Gray; C J Campbell; L J Duncan; J W Farquhar; H Vaughan; P J Morris
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

6.  Autoimmunity to anterior pituitary cells and the pathogenesis of insulin-dependent diabetes mellitus.

Authors:  R Mirakian; A G Cudworth; G F Bottazzo; C A Richardson; D Doniach
Journal:  Lancet       Date:  1982-04-03       Impact factor: 79.321

7.  Islet-cell-surface antibodies in juvenile diabetes mellitus.

Authors:  A Lernmark; Z R Freedman; C Hofmann; A H Rubenstein; D F Steiner; R L Jackson; R J Winter; H S Traisman
Journal:  N Engl J Med       Date:  1978-08-24       Impact factor: 91.245

8.  Coincident presence of thyro-gastric autoimmunity at onset of type 1 (insulin-dependent) diabetes.

Authors:  W J Riley; A Winer; D Goldstein
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

9.  Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.

Authors:  M J Dobersen; J E Scharff; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

10.  Antimicrosomal antibodies, gastric parietal cell antibodies and antinuclear factors in insulin dependent diabetes mellitus.

Authors:  K Nagaoka; T Sakurami; N Nabeya; H Imura; S Kuno
Journal:  Endocrinol Jpn       Date:  1979-10
View more
  1 in total

1.  Association of Autoimmune Thyroid Disease with Anti-GAD Antibody ELISA Test Positivity and Risk for Insulin Deficiency in Slowly Progressive Type 1 Diabetes.

Authors:  Masahito Katahira; Hidetada Ogata; Takahiro Ito; Tsutomu Miwata; Megumi Goto; Shizuka Nakamura; Hiromi Takashima
Journal:  J Diabetes Res       Date:  2018-07-11       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.